Market Movers

Humana Inc.’s Stock Price Takes a 9.48% Dive, Trading at $228.89 Amid Market Volatility

Humana Inc. (HUM)

228.89 USD -23.97 (-9.48%) Volume: 3.83M

Humana Inc.’s stock price stands at 228.89 USD, experiencing a significant drop of -9.48% this trading session with a trading volume of 3.83M. The healthcare company’s year-to-date performance also shows a decline of -9.78%, indicating a challenging market environment for HUM investors.


Latest developments on Humana Inc.

Today, Humana Inc. (NYSE:HUM) stock price movements were influenced by various key events. Captrust Financial Advisors reduced its holdings in the company, while Fred Alger Management LLC made a significant new investment. Conversely, Baird Financial Group Inc. sold shares of Humana, and Ameriprise Financial Inc. also decreased its holdings. On the other hand, Deutsche Bank AG increased its stock holdings. Additionally, Rep. Gilbert Ray Cisneros, Jr. sold shares of Humana, and various other financial institutions such as Jacobs Levy Equity Management Inc., Colonial Trust Co SC, and Ensign Peak Advisors Inc. made changes to their positions in the company. Overall, brokerages have given Humana Inc. an average rating of “Hold,” with StockNews.com recently upgrading the stock to a Buy rating.


Humana Inc. on Smartkarma

Analysts on Smartkarma, such as Value Investors Club, have been covering Humana Inc, a company that provides Medicare Advantage plans to around 6 million members. The analysts highlighted Humana’s focus on promoting value-based care relationships with providers and incentivizing cost-saving behavior to provide efficient and high-quality care. The research report published on Monday, Oct 28, 2024, showed a bullish sentiment towards Humana Inc.

According to Value Investors Club, Humana Inc‘s Medicare Advantage plans limit provider networks and treatments, aiming to pay for outcomes rather than the volume of services provided. This approach aligns with the company’s goal of focusing on preventative treatment and delivering value-based care. The research report, published 3 months ago, provides valuable insights into Humana Inc‘s business model and its strategies in the healthcare industry.


A look at Humana Inc. Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. has been given a positive overall outlook based on Smartkarma Smart Scores. With high scores in Value and Dividend, the company is seen as a strong investment option for those looking for stability and potential returns. Additionally, its Momentum score suggests that Humana is performing well in terms of market trends and investor sentiment.

Although Humana Inc. received slightly lower scores in Growth and Resilience, indicating some room for improvement in these areas, the company’s overall outlook remains favorable. As a managed health care company serving members in the US and Puerto Rico, Humana’s diverse range of health care products and services positions it well for long-term success in the industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars